CHRS - Coherus BioSciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents72,356126,911124,947158,226
Short Term Investments----
Net Receivables--1,8591,560
Inventory1,659---
Other Current Assets1332023,0462,857
Total Current Assets84,433145,477161,486197,386
Long Term Investments----
Property Plant and Equipment6,66012,77310,77210,504
Goodwill943943943943
Intangible Assets2,6202,6202,6202,620
Accumulated Amortization----
Other Assets4,8117982,664931
Deferred Long Term Asset Charges----
Total Assets99,467162,611178,485212,384
Current Liabilities
Accounts Payable15,29415,71420,58329,496
Short/Current Long Term Debt----
Other Current Liabilities4193,6317,77152,389
Total Current Liabilities33,26128,39556,376106,018
Long Term Debt103,092101,608100,256-
Other Liabilities1,7052,0732,499113,295
Deferred Long Term Liability Charges---137
Minority Interest--1,289-1,173-722
Negative Goodwill----
Total Liabilities138,058132,076159,131219,313
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock7654
Retained Earnings-984,831-775,492-537,322-409,985
Treasury Stock-282-750-630-401
Capital Surplus946,515808,060558,474404,175
Other Stockholder Equity-282-750-630-401
Total Stockholder Equity-38,59131,82420,527-6,207
Net Tangible Assets-42,15428,26116,964-9,770